Botswana vs Korea, Democratic People's Republic of: Treatment success rate for patients treated for MDR-TB
Botswana
80.0%
in 2022
Korea, Democratic People's Republic of
80.0%
in 2022
Botswana rank
50th
Korea, Democratic People's Republic of rank
50th
Treatment success rate for patients treated for MDR-TB over time
- Botswana
- Korea, Democratic People's Republic of
How they compare
Botswana currently reports 80.0% against 80.0% in Korea, Democratic People's Republic of, a difference of 0.0%.
Across all 10 years both countries report, Korea, Democratic People's Republic of has been ahead every year.
Botswana ranks 50th and Korea, Democratic People's Republic of ranks 50th of 163 countries.
Korea, Democratic People's Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Botswana | Korea, Democratic People's Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 68.1% | 79.9% | 11.8% | Korea, Democratic People's Republic of |
| 2020s | 72.5% | 80.0% | 7.5% | Korea, Democratic People's Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Botswana or Korea, Democratic People's Republic of?
- Botswana, at 80.0% against 80.0% in Korea, Democratic People's Republic of as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Botswana and Korea, Democratic People's Republic of?
- 0.0%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Korea, Democratic People's Republic of?
- 10 years are reported by both, from 2012 to 2022.
- How do Botswana and Korea, Democratic People's Republic of rank globally for treatment success rate for patients treated for mdr-tb?
- Botswana ranks 50th and Korea, Democratic People's Republic of ranks 50th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.